Mankind Pharma’s chairman has said the company’s will launch the cheapest Molnupiravir, the Covid-19 antiviral drug, at Rs 35 per capsule, the Economic Times said in a report. Molnupiravir, developed by MSD and Ridgeback Biotherapeutics, has been approved by the UK Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration for the treatment of mild-to-moderate Covid-19 …
Drug firm Mankind Pharma on Thursday said it has received licence from the Defence Research and Development Organisation to manufacture and market oral 2-deoxy-D-glucose, used for the treatment of COVID-19. The clinical trials for 2-DG were conducted by the Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in association with Dr Reddy’s Laboratories, Mankind Pharma said in …
Disease X: The next pandemic: The year 2021 has undoubtedly pinned hopes to mankind in terms of relief from the ongoing coronavirus pandemic, even though the new strain has already set its foot in India and across several nations. A new deadly virus - Disease X, is set to hit mankind, and this has been revealed by the doctor who …
)
